Learn about the program's unique curriculum, world-class faculty and convenient schedule. In just two years, you can earn your degree while still working full-time.
Richard Moss, Ph.D.
Senior Associate Dean for Basic Research, Biotechnology and Graduate Studies
Executive Director and Co-founder, M.S. in Biotechnology Program
Kurt Zimmerman, M.S.
Director, Industry Engagement, SMPH
Director, Master of Science in Biotechnology Program
Natalie Betz, Ph.D.
Associate Director and Faculty Instructor, Master of Science in Biotechnology Program
Bryan Husk, M.A.
Assistant Director, Master of Science in Biotechnology Program
Michele Smith, MS SCT(ASCP)
Program Manager, Master of Science in Biotechnology Program
The Master of Science of Biotechnology Program brings together the expertise of the University of Wisconsin's world-class faculty, and the applied experience of the region's most successful biotechnology leaders from private industry.
Natalie Betz, Ph.D.
Associate Director and Faculty Instructor
Master of Science in Biotechnology
Dave Lewis, Ph.D.
Chief Scientific Officer (former)
UW Carbone Cancer Center
The M.S. in Biotechnology program has over 300 alumni since its first graduates in 2004.
Each year the value of the alumni network strengthens as more students graduate and grow their careers.
Alumni by Graduating Class:
Dr. Hei attended the University of Wisconsin, Madison and received a Bachelor of Science degree in Chemical Engineering graduating with honors in June of 1988. He then attended the University of California, Berkeley where he completed his Ph.D. in Biochemical Engineering in 1993. Following his Ph.D. research, Dr. Hei joined Genentech (South San Francisco, CA) as a scientist in the Process Recovery R&D group. At Genentech, he was primarily involved in developing processes and methods for producing and testing protein biopharmaceuticals. Dr. Hei joined Cerus Corp (Concord, CA) in May of 1994. There he established the Biomedical Engineering group and directed the development of novel separation devices for transfusable blood products. The Biomedical Engineering group at Cerus developed medical devices for treating transfusable platelets, plasma, and red blood cells and filed several patents based on this work. These devices are currently in phase III human clinical trials.
Derek Hei joined UW, Madison in January of 2000 to act as the Technical Director of the Waisman Clinical Biomanufacturing Facility (WCBF). As Technical Director of the WCBF, Dr. Hei has been primarily responsible for facility start?up including addressing design and construction issues and equipping and staffing this state-of-the-art cleanroom facility for manufacturing biotherapeutics. Currently, Dr. Hei interacts with UW investigators to address technical issues related to the development and production of cutting-edge experimental drugs for gene therapy, cell therapy, and immunotherapy.
Dr. Derek Hei serves as an instructor for the course entitled "Biotechnology Operations". Dr. Hei provides instruction in Manufacturing and Control for biotechnology products. A critical requirement for the instructor of this course is comprehensive experience in developing and manufacturing a broad range of biotechnology products. In addition to understanding various manufacturing processes and issues related to process design and scale-up, the instructor must understand FDA regulations and how these regulations impact product and process development and design.
Prospective StudentsBiotech at UW-Madison
Students & AlumniAlumni Success Stories